Li N. Komatsu

Array ( [id] => 8834522 [patent_doc_number] => 08450278 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-28 [patent_title] => 'MUC18 targeting peptides' [patent_app_type] => utility [patent_app_number] => 13/124550 [patent_app_country] => US [patent_app_date] => 2009-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18227 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13124550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11204993 [patent_doc_number] => 09434610 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-06 [patent_title] => 'HPMA—docetaxel conjugates and uses therefore' [patent_app_type] => utility [patent_app_number] => 12/575276 [patent_app_country] => US [patent_app_date] => 2009-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10292 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12575276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8802518 [patent_doc_number] => 08440794 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-14 [patent_title] => 'Peptide sequences, their branched form and use thereof for antimicrobial applications' [patent_app_type] => utility [patent_app_number] => 13/122426 [patent_app_country] => US [patent_app_date] => 2009-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5272 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13122426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6162943 [patent_doc_number] => 20110160137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'COMPOSITION CONTAINING COLLAGEN PEPTIDE FOR IMPROVING SKIN CARE' [patent_app_type] => utility [patent_app_number] => 13/060825 [patent_app_country] => US [patent_app_date] => 2009-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4987 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160137.pdf [firstpage_image] =>[orig_patent_app_number] => 13060825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6062071 [patent_doc_number] => 20110200558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'Treatment or Prevention of Hepatitis C with Immunomodulator Compounds' [patent_app_type] => utility [patent_app_number] => 13/057745 [patent_app_country] => US [patent_app_date] => 2009-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5001 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20110200558.pdf [firstpage_image] =>[orig_patent_app_number] => 13057745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9710825 [patent_doc_number] => 08835393 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-16 [patent_title] => 'Inhibitors of IAP' [patent_app_type] => utility [patent_app_number] => 13/057176 [patent_app_country] => US [patent_app_date] => 2009-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15634 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13057176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5304101 [patent_doc_number] => 20090298753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'METHODS FOR THE THERAPEUTIC USE OF CYCLOSPORINE COMPONENTS' [patent_app_type] => utility [patent_app_number] => 12/506612 [patent_app_country] => US [patent_app_date] => 2009-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4895 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298753.pdf [firstpage_image] =>[orig_patent_app_number] => 12506612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6189772 [patent_doc_number] => 20110172141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'PROCESS FOR PREPARING MICROPARTICLES' [patent_app_type] => utility [patent_app_number] => 13/003506 [patent_app_country] => US [patent_app_date] => 2009-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7866 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20110172141.pdf [firstpage_image] =>[orig_patent_app_number] => 13003506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6144501 [patent_doc_number] => 20110130343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'IMMUNITY-INDUCING AGENT AND METHOD FOR DETECTION OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/002629 [patent_app_country] => US [patent_app_date] => 2009-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 21021 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20110130343.pdf [firstpage_image] =>[orig_patent_app_number] => 13002629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9183394 [patent_doc_number] => 08623326 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-07 [patent_title] => 'Ghrelin analogues' [patent_app_type] => utility [patent_app_number] => 12/994259 [patent_app_country] => US [patent_app_date] => 2009-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 8813 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12994259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10000411 [patent_doc_number] => 09044486 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-02 [patent_title] => 'Method for prophylaxis or treatment of feline infectious peritonitis' [patent_app_type] => utility [patent_app_number] => 12/935967 [patent_app_country] => US [patent_app_date] => 2009-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 6486 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12935967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6071190 [patent_doc_number] => 20110046041 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'METHODS OF INHIBITING AND TREATING BIOFILMS USING GLYCOPEPTIDE ANTIBIOTICS' [patent_app_type] => utility [patent_app_number] => 12/936722 [patent_app_country] => US [patent_app_date] => 2009-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 23240 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20110046041.pdf [firstpage_image] =>[orig_patent_app_number] => 12936722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6212361 [patent_doc_number] => 20110135661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'TREATMENT AND PREVENTION OF DRY AGE-RELATED MACULAR DEGENERATION BY ACTIVATING CD36' [patent_app_type] => utility [patent_app_number] => 12/735808 [patent_app_country] => US [patent_app_date] => 2009-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11240 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20110135661.pdf [firstpage_image] =>[orig_patent_app_number] => 12735808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8920959 [patent_doc_number] => 08486892 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-16 [patent_title] => 'Blood coagulation factor inhibitors' [patent_app_type] => utility [patent_app_number] => 12/811854 [patent_app_country] => US [patent_app_date] => 2009-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16774 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12811854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6144488 [patent_doc_number] => 20110130338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'USE OF SERINE PROTEASE INHIBITORS IN THE TREATMENT OF SKIN DISEASES' [patent_app_type] => utility [patent_app_number] => 12/863651 [patent_app_country] => US [patent_app_date] => 2009-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 25199 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20110130338.pdf [firstpage_image] =>[orig_patent_app_number] => 12863651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8982266 [patent_doc_number] => 08513381 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-20 [patent_title] => 'Melanocortin analogs with antimicrobial activity' [patent_app_type] => utility [patent_app_number] => 13/144858 [patent_app_country] => US [patent_app_date] => 2009-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3622 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13144858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6071204 [patent_doc_number] => 20110046055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'THERAPEUTIC AGENT FOR DIABETES' [patent_app_type] => utility [patent_app_number] => 12/740362 [patent_app_country] => US [patent_app_date] => 2008-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7286 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20110046055.pdf [firstpage_image] =>[orig_patent_app_number] => 12740362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6535412 [patent_doc_number] => 20100204144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'USE OF THE PEPTIDES MAIPPKKNQDK (COW KAPPA CASEIN 106-116) AND/OR YGFQNA (SERORPHIN) AS THERAPEUTIC AGENTS' [patent_app_type] => utility [patent_app_number] => 12/677773 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35265 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204144.pdf [firstpage_image] =>[orig_patent_app_number] => 12677773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6326953 [patent_doc_number] => 20100197605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'THERAPEUTIC USE OF PEPTIDE YGLF AND COMBINATION WITH KVLPVPQ' [patent_app_type] => utility [patent_app_number] => 12/677766 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35207 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20100197605.pdf [firstpage_image] =>[orig_patent_app_number] => 12677766 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6506858 [patent_doc_number] => 20100210555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'USE OF A LAMININ PEPTIDE AS A THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 12/677353 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35579 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210555.pdf [firstpage_image] =>[orig_patent_app_number] => 12677353 [rel_patent_id] =>[rel_patent_doc_number] =>)